If we further extended the criterion to include individuals with CD4+ T-cell counts of 350–500 cells/mm3, the magnitude of these losses would be even greater, because the use of ART at that stage of infection could reduce sexual HIV transmission by 90% and the incidence of AIDS-related diseases by 40% [2]. This evidence concerns the gene CD4 and infection.